甲磺酸伊馬替尼基本信息MSDS用途與合成方法甲磺酸伊馬替尼價(jià)格(試劑級(jí))上下游產(chǎn)品信息專題中文名稱:甲磺酸伊馬替尼中文同義詞:伊馬替尼甲磺酸酯;甲磺酸伊馬替尼;伊馬替尼/甲磺酸伊馬替尼;IMA錫IB甲磺酸鹽;甲磺酸伊馬替你;甲磺酸伊馬替尼99%;甲苯磺酸伊馬替尼;甲磺酸伊馬替尼Α晶型;甲磺酸伊馬替尼英文名稱:Imatinibmesylate英文同義詞:Imatinibforsystemsuitability;GLIVEC;CGP-57148B;STI-571;Imatinibmesylate/4-[(4-Methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamidemethanesulfonate;4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[[4-(3-pyridyl)pyrimidin-2-yl]amino]phenyl]benzamide;Gleevec(Imatinib);IMatinibMesylate(STI-571);Imantinibmesylate;4-[(4-Methyl-1-piperazinyl)Methyl]-N-[4-Methyl-3-[[4-(3-pyridinyl)-2-pyriMidinyl]aMino]phenyl]benzaMideMethanesulfonateCAS號(hào):220127-57-1分子式:C30H35N7O4S分子量:589.71EINECS號(hào):606-892-3相關(guān)類別:原料;抗腫瘤;抗腫瘤藥物;原料藥;雜質(zhì);細(xì)胞生物學(xué)試劑;化工中間體;農(nóng)藥中間體;醫(yī)藥原料藥;TINIBS替尼類產(chǎn)品(Anti-cancer);醫(yī)藥中間體;原料藥標(biāo)樣;蛋白酪氨酸激酶;治療白血病;中間體;抗腫瘤類;小分子抑制劑;小分子抑制劑，天然產(chǎn)物;醫(yī)藥原料;化合物;Intermediates&FineChemicals;Pharmaceuticals;TyrosineKinaseInhibitors;Aromatics;Heterocycles;API;Glivec,CGP-57148B,STI-571;醫(yī)藥原料藥-原料藥;ActivePharmaceuticalIngredients;Antineoplastic;Anti-cancer&immunity;Inhibitors;Anticancer;醫(yī)藥酪氨酸激酶抑制劑Mol文件:220127-57-1.mol